Scientists hail new prostate cancer drug

SCIENTISTS yesterday hailed a new chemotherapy drug as the first ever treatment to prolong life for men with advanced prostate cancer.

There are about 1,000 new cases diagnosed each year in Ireland.

Researchers found those who trialled cabazitaxel in the latter, more aggressive stages of the disease, lived on average 30% longer than those taking another medication.